Medifast Inc Stock EBITDA
| MED Stock | USD 33.57 0.15 0.45% |
MEDIFAST INC fundamentals help investors to digest information that contributes to MEDIFAST INC's financial success or failures. It also enables traders to predict the movement of MEDIFAST Stock. The fundamental analysis module provides a way to measure MEDIFAST INC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MEDIFAST INC stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 139.5 M | 146.5 M |
MEDIFAST | EBITDA |
MEDIFAST INC Company EBITDA Analysis
MEDIFAST INC's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current MEDIFAST INC EBITDA | 139.51 M |
Most of MEDIFAST INC's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MEDIFAST INC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
MEDIFAST EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for MEDIFAST INC is extremely important. It helps to project a fair market value of MEDIFAST Stock properly, considering its historical fundamentals such as EBITDA. Since MEDIFAST INC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MEDIFAST INC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MEDIFAST INC's interrelated accounts and indicators.
Click cells to compare fundamentals
MEDIFAST EBITDA Historical Pattern
Today, most investors in MEDIFAST INC Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MEDIFAST INC's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of MEDIFAST INC ebitda as a starting point in their analysis.
MEDIFAST INC EBITDA |
| Timeline |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
MEDIFAST Ebitda
Ebitda |
|
According to the company disclosure, MEDIFAST INC reported earnings before interest,tax, depreciation and amortization of 139.51 M. This is 86.42% lower than that of the Personal Care Products sector and 64.13% lower than that of the Consumer Staples industry. The ebitda for all United States stocks is 96.42% higher than that of the company.
MEDIFAST EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MEDIFAST INC's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MEDIFAST INC could also be used in its relative valuation, which is a method of valuing MEDIFAST INC by comparing valuation metrics of similar companies.MEDIFAST INC is currently under evaluation in ebitda category among related companies.
MEDIFAST INC Institutional Holders
Institutional Holdings refers to the ownership stake in MEDIFAST INC that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of MEDIFAST INC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing MEDIFAST INC's value.| Shares | Bank Of New York Mellon Corp | 2023-12-31 | 201.1 K | Charles Schwab Investment Management Inc | 2023-12-31 | 186.2 K | Hotchkis & Wiley Capital Management Llc | 2023-12-31 | 167.3 K | American Century Companies Inc | 2023-12-31 | 139.9 K | Jacobs Levy Equity Management, Inc. | 2023-09-30 | 129.7 K | Northern Trust Corp | 2023-12-31 | 125.5 K | Aqr Capital Management Llc | 2023-12-31 | 110.4 K | Ubs Group Ag | 2023-12-31 | 92 K | Ameriprise Financial Inc | 2023-12-31 | 91.3 K | Blackrock Inc | 2023-12-31 | 1.8 M | Vanguard Group Inc | 2023-12-31 | 1.7 M |
MEDIFAST Fundamentals
| Return On Equity | 0.56 | ||||
| Return On Asset | 0.25 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 223.45 M | ||||
| Shares Outstanding | 10.9 M | ||||
| Shares Owned By Insiders | 2.70 % | ||||
| Shares Owned By Institutions | 97.75 % | ||||
| Number Of Shares Shorted | 2.66 M | ||||
| Price To Earning | 13.99 X | ||||
| Price To Book | 1.70 X | ||||
| Price To Sales | 0.32 X | ||||
| Revenue | 1.07 B | ||||
| Gross Profit | 1.14 B | ||||
| EBITDA | 139.51 M | ||||
| Net Income | 99.42 M | ||||
| Cash And Equivalents | 87.69 M | ||||
| Cash Per Share | 5.57 X | ||||
| Total Debt | 22.01 M | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 1.29 X | ||||
| Book Value Per Share | 18.69 X | ||||
| Cash Flow From Operations | 147.66 M | ||||
| Short Ratio | 5.83 X | ||||
| Earnings Per Share | 9.10 X | ||||
| Price To Earnings To Growth | 1.95 X | ||||
| Target Price | 37.5 | ||||
| Number Of Employees | 634 | ||||
| Beta | 1.15 | ||||
| Market Capitalization | 364.13 M | ||||
| Total Asset | 309.91 M | ||||
| Retained Earnings | 174.65 M | ||||
| Working Capital | 131.73 M | ||||
| Current Asset | 88.07 M | ||||
| Current Liabilities | 23.56 M | ||||
| Annual Yield | 0.20 % | ||||
| Five Year Return | 2.53 % | ||||
| Net Asset | 309.91 M | ||||
| Last Dividend Paid | 4.95 |
About MEDIFAST INC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MEDIFAST INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MEDIFAST INC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MEDIFAST INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out MEDIFAST INC Piotroski F Score and MEDIFAST INC Altman Z Score analysis. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 4.95 | Earnings Share 9.1 | Revenue Per Share 98.498 | Quarterly Revenue Growth (0.43) |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.